'Tnf inhibitor' presentation slideshows

4 January 2020 4:04 AM

2004-2005 Pharmacology Review of Everything (Principles, Cardiovascular and Respiratory drugs have been updated). 4 January 2020 4:04 AM. Abacavir. Antiretroviral Nucleoside reverse transcriptase inhibitor (NRTI). Abciximab. Antiplatelet Anti-GPIIb/IIIa receptor antibody. Acarbose.

6.93k views • 693 slides

952 views • 60 slides

Jacques-Eric Gottenberg Universitary Hospital of Strasbourg, France

How real life rituximab data supports the use of rituximab following an inadequate response to one TNF inhibitor. Jacques-Eric Gottenberg Universitary Hospital of Strasbourg, France National center for systemic autoimmune diseases. Main objections to rituximab.

464 views • 20 slides

Con arguments: Maxime DOUGADOS

403 views • 20 slides

Switching to a second TNF-antagonist. Why not?

Switching to a second TNF-antagonist. Why not?. Emilio Martin Mola Hospital Universitario La Paz. Madrid.

261 views • 20 slides

Professor Robert J Moots

270 views • 17 slides

MGNS

MGNS. Heidi Johnson-Gazzard IBD CNS, City Hospital, Birmingham. INFLIXIMAB. INFLIXIMAB WAS LICENSED AS A TREATMENT FOR SEVERE CROHNS DISEASE IN ADULTS IN AUGUST 1999 SINCE THEN, THE NUMBERS OF PTS RECEIVING INFLIXIMAB HAS GROWN SIGNIFICANTLY ITS USE IS NOW COMMONPLACE IN MANAGING SEVERE IBD.

344 views • 15 slides

2003-2004 Review of IBS/IBD Drug Treatments

2003-2004 Review of IBS/IBD Drug Treatments. 20 August 2014 2:08 AM. Alosetron. IBS treatment 5HT 3 receptor antagonist. Balsalazide. NSAID (salicylate) Treatment of IBD. Budesonide. Adrenocorticosteroid Glucocorticoid Anti-inflammatory steroid Inhaled OR treatment of IBD. Infliximab.

188 views • 9 slides